Skip to content
10-K

Annual Report

GREENWICH LIFESCIENCES, INC. GLSI

0001641172-25-004819

← back to feed
Filed
Apr 15, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Apr 11, 2025 13.27M sh
Shares Diluted FY 2024 · Dec 31, 2023 12.85M sh
Operating Cash Flow FY 2024 · Dec 31, 2023 −$6.48M
Cash And Equivalents FY 2024 · Dec 31, 2023 $6.99M
Current Liabilities FY 2024 · Dec 31, 2023 $294.41K
Total Liabilities FY 2024 · Dec 31, 2023 $294.41K
Total Assets FY 2024 · Dec 31, 2023 $6.99M
Eps Diluted FY 2024 · Dec 31, 2023 −$0.69
Eps Basic FY 2024 · Dec 31, 2023 −$0.69
Sga Expense FY 2024 · Dec 31, 2023 $1.63M
Rd Expense FY 2024 · Dec 31, 2023 $7.7M
Net Income FY 2024 · Dec 31, 2023 −$8.89M
Operating Income FY 2024 · Dec 31, 2023 −$9.33M
Stockholders Equity FY 2024 · Dec 31, 2022 $13.21M